Blog

Proteoforms, metastasis, and cancer therapy responses – Applications of proteomics in cancer

Recent research showcases the diversity of proteoforms in cancer cells and demonstrates how they change upon drug treatment and metastasis.

Spatial Proteomics with Fiona Ginty Ph.D. – Translating Proteomics

Parag Mallick interviews spatial proteomics pioneer Fiona Ginty Ph.D. on the Translating Proteomics podcast.

Proteomics and the food of the future

Learn how proteomics may change the future of food.

Proteoforms and EGFR signaling – Applications of proteomics in cancer

Learning more about EGFR proteoforms may help us understanding and treat cancer.

Life at Nautilus Interview with Denise Miller – Associate Director of Software Engineering

Learn why Denise Miller, Associate Director of Software Engineering, is excited to use her expertise to help build the Nautilus Platform.

Unlocking the potential of plasma proteomics

Learn about the challenges and opportunities in plasma proteomics.

Intro to Proteomics – Translating Proteomics

Listen to this episode of Translating Proteomics for a refresher on the basics of proteomics or to get started in the field.

Life at Nautilus Interview with Michael Darcy Ph.D. – Senior Scientist

Nautilus Senior Scientist Michael Darcy shares why he's exciting to work a an entirely new way to do proteomics.

How AI is Changing the Future of Biotech Research

Why is biological data so complicated? What’s driving the rise of AI and machine learning in biotech? In this article, we answer these questions and discuss the future of AI in biotech.

Proteomics Podcast Crossover – The Proteomics Show

Nautilus Co-Founder and Chief Scientist Parag Mallick is interview by Ben Orsburn and Ben Neely of The Proteomics Show.

US HUPO 2025 – Key Takeaways, Trends, and Future Directions for Proteomics

Parag Mallick and Andreas Huhmer share their takeaways from US HUPO 2025 on this episode of Translating Proteomics.

Proteoforms and Alzheimer’s disease

Learn how tau and amyloid beta proteoforms may contribute to Alzhiemer's disease